Phase 1 Influenza virus Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age
Human MetapneumovirusHuman Parainfluenza Virus Type 3
National Institute of Allergy and Infectious Diseases (NIAID)25 enrolled4 locationsNCT06546423
Recruiting
Phase 1
Coadministration of Malignancy and Infection specific T cells after allogeneic stem cell Transplant for Acute Leukaemia with CD34+ selected stem cells
AspergillusInfluenza virusBK Virus+2 more
Western Sydney Local Health District, Westmead Hospital20 enrolled1 locationACTRN12618001090202